NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use

Arne Kristian Skulberg, Ida Tylleskär, Anne-Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Sindre Mellesmo, Morten Valberg, Ola Dale

Open source

DOI
10.1136/bmjopen-2020-041556
Published
2020-11
Container
BMJ Open
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2020-041556,
  title = {NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use},
  author = {Arne Kristian Skulberg and Ida Tylleskär and Anne-Cathrine Braarud and Jostein Dale and Fridtjof Heyerdahl and Sindre Mellesmo and Morten Valberg and Ola Dale},
  year = {2020},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2020-041556},
  url = {https://doi.org/10.1136/bmjopen-2020-041556}
}

RIS

TY  - JOUR
TI  - NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use
AU  - Arne Kristian Skulberg
AU  - Ida Tylleskär
AU  - Anne-Cathrine Braarud
AU  - Jostein Dale
AU  - Fridtjof Heyerdahl
AU  - Sindre Mellesmo
AU  - Morten Valberg
AU  - Ola Dale
PY  - 2020
JO  - BMJ Open
DO  - 10.1136/bmjopen-2020-041556
UR  - https://doi.org/10.1136/bmjopen-2020-041556
ER  - 

APA

Skulberg, A. K., Tylleskär, I., Braarud, A., Dale, J., Heyerdahl, F., Mellesmo, S., Valberg, M., & Dale, O. (2020). NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. BMJ Open. https://doi.org/10.1136/bmjopen-2020-041556

Source records